Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
Agomab Therapeutics proposed the appointment of Marino Garcia and Dr. Naimish Patel to its Board of Directors, with shareholder approval slated for a Special General Meeting on September 11, 2026. Garcia, currently CEO of Dianthus Therapeutics, brings financing and growth expertise, while Patel, CMO of CRISPR Therapeutics, adds deep clinical development and immunology experience.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.